Kieron M. Craine
Papers
1
Total Citations
89
H-Index
1
About
Kieron M. Craine is a leading researcher in microbial glycobiology, with a primary focus on the therapeutic applications of alginate oligosaccharides derived from seaweed. His most significant contribution is the characterization of OligoG, a low-molecular-weight alginate that exhibits potent anti-biofilm and antimicrobial properties. In his highly cited 2014 study (89 citations), Craine demonstrated that OligoG not only inhibits the growth of pathogenic fungi like *Candida* and *Aspergillus* species but also synergistically potentiates the activity of conventional antifungal drugs. This work has profound implications for combating multi-drug resistant infections, a critical global health challenge. By bridging the gap between marine natural products and clinical microbiology, Craine’s research has opened new avenues for developing combination therapies that enhance the efficacy of existing antifungals while reducing required dosages. His findings are particularly impactful for immunocompromised patients vulnerable to fungal infections, positioning him as a key innovator in the fight against antimicrobial resistance.
Research Focus
Key Achievements
Top Papers
- 1